Cyprus · TED award notices · Supplier record
GENESIS PHARMA (CYPRUS) LTD — Cyprus · TED award notices · Supplier record: 23 award notices, all years (Feb 2024 – Jun 2026); 23 since January 2024 (1 buyer); 12th rank in the line (of 34 suppliers · 4.4%); 2 buyers never served (2 notices in the line from them).
Assay record ASY-CY-05NSSVI0PA · Cite as: Assay Systems, “GENESIS PHARMA (CYPRUS) LTD: 23 award notices in Cyprus since 2024”, https://assay-systems.com/register/cy/genesis-pharma-cyprus-ltd/
GENESIS PHARMA (CYPRUS) LTD won 20 of its 23 public contract awards in Cyprus without a rival from 2024-02-09 to 2026-06-01: 13 without a competition and 7 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Ypourgeio Ygeias with 20.
Buyers: Ypourgeio Ygeias (20)
Every uncontested award of GENESIS PHARMA (CYPRUS) LTD · Cyprus: all uncontested awards
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (CPV 33650000)
Every buyer, every supplier, award date, notice number and value where one is disclosed, behind the figures above.
Source: contract award notices for Cyprus in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 16 October 2026.Assay Systems has changed the data.